Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol plus drospirenone versus estradiol plus norethisterone acetate effects on mammographic density in postmenopausal women
2008-003654-15Phase 4Active
- Sponsor
- Karolinska University Hospital
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in menopause comparing Estradiol + drospirenone with Estradiol + norethisterone acetate (2 arms). Primary endpoint: Mammographic breast density. Started Jul 2008; status: active.
02
Drugs
estradioldrospirenonenorethisterone acetate
03
Conditions
menopause
Beyond the preview
Go deeper on 2008-003654-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003654-15.